HEM — Hemostemix Cashflow Statement
0.000.00%
Last trade - 00:00- CA$16.96m
- CA$19.11m
Annual cashflow statement for Hemostemix, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.77 | -6.29 | -5.24 | -2.5 | -2.62 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.62 | 0.247 | 0.351 | 0.527 | 0.946 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.826 | 2.82 | -1.71 | 0.555 | -0.232 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -5.98 | -3.48 | -6.1 | -1.42 | -1.9 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.171 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0.171 | 0 | — | — |
| Financing Cash Flow Items | -0.707 | -0.064 | -0.202 | -0.078 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.21 | 3.27 | 6.02 | 1.44 | 2.45 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.234 | -0.039 | -0.084 | 0.02 | 0.55 |